Soleno Therapeutics

Patent cliffs & loss of exclusivity

Company

Legal NameSoleno Therapeutics, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/soleno-therapeutics
Facebook URLhttps://www.facebook.com/SolenoTx/
Full Address203 Redwood Shores Parkway Suite 500 Redwood City, CA 94065
LinkedIn URLhttps://www.linkedin.com/company/soleno/
Pitchbook URLhttps://pitchbook.com/profiles/company/56393-56
Seedtable URLhttps://seedtable.com/companies/soleno-therapeutics

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. VYKAT XRDIAZOXIDE CHOLINESmall mol.Nov 2035
  2. VYKAT XRDIAZOXIDE CHOLINESmall mol.Nov 2035
  3. VYKAT XRDIAZOXIDE CHOLINESmall mol.Nov 2035

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Soleno Therapeutics — patent cliffs & loss of exclusivity | CliffBio